Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of OraTest for Oral Lesion Detection
NCT00537199Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolonium chloride in head and neck cancer (HNC), oropharyngeal cancer, oral cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2006; status: terminated.
02
Drugs
tolonium chloride
03
Conditions
head and neck cancer (HNC)oropharyngeal canceroral cancer
Beyond the preview
Go deeper on NCT00537199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537199.